Dynamic reorganization of the astrocyte actin cytoskeleton elicited by cAMP and PACAP: a role for phosphatidylInositol 3-kinase inhibition

Eur J Neurosci. 2005 Jan;21(1):26-32. doi: 10.1111/j.1460-9568.2004.03845.x.

Abstract

Cyclic AMP (cAMP)-raising agents induce astrocytes grown in vitro to adopt a stellate morphology resembling their in vivo appearance, through the depolymerization of actomyosin stress fibres. The signalling pathways responsible for cAMP-induced astrocyte stellation have thus far remained largely elusive. We showed in this study that the neurotrophic peptide PACAP (pituitary adenylate cyclase-activating polypeptide) mimicked the effect of forskolin, a direct activator of adenylate cyclase, on the actin cytoskeleton of primary rat astrocytes. The depolymerization of stress fibres induced by PACAP or forskolin was prevented by the expression of a constitutively active mutant of RhoA, but not by a protein kinase A (PKA) blocker, indicating that cAMP-raising agents act upstream of RhoA, in a PKA-independent manner. In addition, PACAP and forskolin inhibited basal Akt phosphorylation, and basal and epidermal growth factor (EGF)-stimulated phosphatidylinositol 3-kinase (PI 3-K) activities. Incubation with a PI 3-K blocker resulted in the depolymerization of stress fibres. This effect was blocked by the expression of a constitutively active mutant of RhoA, indicating that PI 3-K inhibition acted upstream of RhoA. Together, these data demonstrate for the first time that depolymerization of stress fibres, and the resulting astrocyte stellation, induced by stimulation of cAMP production involves the inhibition of the PI 3-K-RhoA pathway.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism*
  • Animals
  • Animals, Newborn
  • Astrocytes / drug effects*
  • Astrocytes / metabolism
  • Blotting, Western / methods
  • Cell Count / methods
  • Cells, Cultured
  • Cerebellum / cytology
  • Chromones / pharmacology
  • Colforsin / pharmacology
  • Cyclic AMP / pharmacology*
  • Drug Interactions
  • Gene Expression Regulation / drug effects
  • Glial Fibrillary Acidic Protein / metabolism
  • Green Fluorescent Proteins / metabolism
  • Immunohistochemistry / methods
  • Indoles / metabolism
  • Morpholines / pharmacology
  • Mutation / genetics
  • Nerve Growth Factors / pharmacology*
  • Neuropeptides / pharmacology*
  • Neurotransmitter Agents / pharmacology*
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-akt
  • Rats
  • Rats, Wistar
  • Time Factors
  • Transfection / methods
  • rhoA GTP-Binding Protein / biosynthesis
  • rhoA GTP-Binding Protein / genetics

Substances

  • Actins
  • Adcyap1 protein, rat
  • Chromones
  • Glial Fibrillary Acidic Protein
  • Indoles
  • Morpholines
  • Nerve Growth Factors
  • Neuropeptides
  • Neurotransmitter Agents
  • Phosphoinositide-3 Kinase Inhibitors
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Proto-Oncogene Proteins
  • Green Fluorescent Proteins
  • Colforsin
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • DAPI
  • Cyclic AMP
  • Akt1 protein, rat
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • rhoA GTP-Binding Protein